Literature DB >> 7539970

Characterization of the leader papain-like proteinase of MHV-A59: identification of a new in vitro cleavage site.

P J Bonilla1, S A Hughes, J D Piñón, S R Weiss.   

Abstract

Sequence analysis of the mouse hepatitis virus, strain A59 (MHV-A59) genome predicts the presence of two papain-like proteinases encoded within the first open reading frame (ORF 1a) of the replicase gene. The more 5' of these domains, the leader papain-like proteinase, is responsible for the cleavage of the amino terminal protein, p28. The core of this proteinase domain was defined to between amino acids 1084 and 1316 from the beginning of ORF 1a. Through the use of deletion analysis coupled with in vitro expression, we studied the role of the coding region between p28 and the leader papain-like proteinase on the cleavage of p28 itself. Expression of a series of deletion mutants showed processing of p28, albeit at lower levels. Reduced p28 production resulting from a 0.4-kb deletion positioned between p28 and the proteinase domain suggests an involvement of this region in catalytic processing. Some mutants displayed cleavage patterns indicative of a second cleavage site. Interestingly, this new cleavage site identified in vitro maps to a position similar to the expected cleavage site of a p65 polypeptide detected in MHV-A59-infected cells. Mutagenesis of the catalytic His1272 residue demonstrates that both cleavages observed are mediated by the leader papain-like proteinase encoded in ORF 1a.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539970     DOI: 10.1006/viro.1995.1281

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Identification of mouse hepatitis virus papain-like proteinase 2 activity.

Authors:  A Kanjanahaluethai; S C Baker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Replication of murine hepatitis virus is regulated by papain-like proteinase 1 processing of nonstructural proteins 1, 2, and 3.

Authors:  Rachel L Graham; Mark R Denison
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

4.  Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication.

Authors:  John Ziebuhr; Barbara Schelle; Nadja Karl; Ekaterina Minskaia; Sonja Bayer; Stuart G Siddell; Alexander E Gorbalenya; Volker Thiel
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Rubella virus nonstructural protein protease domains involved in trans- and cis-cleavage activities.

Authors:  Y Liang; J Yao; S Gillam
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes.

Authors:  A C Sims; J Ostermann; M R Denison
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Characterization of the rubella virus nonstructural protease domain and its cleavage site.

Authors:  J P Chen; J H Strauss; E G Strauss; T K Frey
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Dissection of amino-terminal functional domains of murine coronavirus nonstructural protein 3.

Authors:  Kelley R Hurst-Hess; Lili Kuo; Paul S Masters
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

9.  Suppression of coronavirus replication by inhibition of the MEK signaling pathway.

Authors:  Yingyun Cai; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication.

Authors:  Mark R Denison; Boyd Yount; Sarah M Brockway; Rachel L Graham; Amy C Sims; XiaoTao Lu; Ralph S Baric
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.